Amicus Other Current Liab from 2010 to 2025

FOLD Stock  USD 9.49  0.30  3.26%   
Amicus Therapeutics' Other Current Liabilities is increasing over the years with slightly volatile fluctuation. Overall, Other Current Liabilities is expected to go to about 114.7 M this year. During the period from 2010 to 2025 Amicus Therapeutics Other Current Liabilities annual values regression line had geometric mean of  14,942,077 and mean square error of 803.8 T. View All Fundamentals
 
Other Current Liabilities  
First Reported
2004-12-31
Previous Quarter
127.6 M
Current Value
109.2 M
Quarterly Volatility
46.9 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Amicus Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amicus Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 9 M, Interest Expense of 52.1 M or Other Operating Expenses of 528.6 M, as well as many indicators such as Price To Sales Ratio of 5.16, Dividend Yield of 0.0 or PTB Ratio of 15.52. Amicus financial statements analysis is a perfect complement when working with Amicus Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Amicus Therapeutics Correlation against competitors.
For information on how to trade Amicus Stock refer to our How to Trade Amicus Stock guide.

Latest Amicus Therapeutics' Other Current Liab Growth Pattern

Below is the plot of the Other Current Liab of Amicus Therapeutics over the last few years. It is Amicus Therapeutics' Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amicus Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Other Current Liab10 Years Trend
Slightly volatile
   Other Current Liab   
1.3M87.7103.100.131.109.114.6915%18%-3%31%-17%5%100%
       Timeline  

Amicus Other Current Liab Regression Statistics

Arithmetic Mean50,370,797
Geometric Mean14,942,077
Coefficient Of Variation99.60
Mean Deviation45,430,547
Median57,139,000
Standard Deviation50,169,805
Sample Variance2517T
Range131.7M
R-Value0.84
Mean Square Error803.8T
R-Squared0.70
Significance0.000051
Slope8,828,781
Total Sum of Squares37755.1T

Amicus Other Current Liab History

2025114.7 M
2024109.2 M
2023131.8 M
2022100.6 M
2021103.5 M
202087.7 M
20191.2 M

About Amicus Therapeutics Financial Statements

Amicus Therapeutics stakeholders use historical fundamental indicators, such as Amicus Therapeutics' Other Current Liab, to determine how well the company is positioned to perform in the future. Although Amicus Therapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Amicus Therapeutics' assets and liabilities are reflected in the revenues and expenses on Amicus Therapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Amicus Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Current Liabilities109.2 M114.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Amicus Therapeutics is a strong investment it is important to analyze Amicus Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amicus Therapeutics' future performance. For an informed investment choice regarding Amicus Stock, refer to the following important reports:
Check out the analysis of Amicus Therapeutics Correlation against competitors.
For information on how to trade Amicus Stock refer to our How to Trade Amicus Stock guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amicus Therapeutics. If investors know Amicus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amicus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.18)
Revenue Per Share
1.736
Quarterly Revenue Growth
0.301
Return On Assets
0.0272
Return On Equity
(0.32)
The market value of Amicus Therapeutics is measured differently than its book value, which is the value of Amicus that is recorded on the company's balance sheet. Investors also form their own opinion of Amicus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Amicus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amicus Therapeutics' market value can be influenced by many factors that don't directly affect Amicus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amicus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amicus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amicus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.